LYMPHOSCINTIGRAPHY IN MALIGNANT-MELANOMA

被引:86
作者
BERMAN, CG [1 ]
NORMAN, J [1 ]
CRUSE, CW [1 ]
REINTGEN, DS [1 ]
CLARK, RA [1 ]
机构
[1] UNIV FLORIDA,H LEE MOFFITT CANC CTR & RES INST,DEPT SURG,TAMPA,FL
关键词
D O I
10.1097/00000637-199201000-00010
中图分类号
R61 [外科手术学];
学科分类号
摘要
The development and rationale for the use of lymphoscintigraphy in the preoperative evaluation of patients with malignant melanoma being considered for elective lymph node dissection is reviewed. This overview is updated by an analysis of 135 patients with early stage malignant melanoma involving the head, neck, shoulders, and trunk at Moffitt Cancer Center and Research Institute at the University of South Florida (Tampa, FL). High discordancy rates (overall, 41%) were seen between drainage patterns predicted from historical anatomical guidelines and those revealed by the lymphoscintigraphic examination. The high discordancy rate was most pronounced in the head (64%) and the neck (73%). Surgical management was changed in 33% of the patients, overall. A preoperative lymphoscintigram is recommended for all patients with melanoma with head, neck, and truncal lesions evaluated for elective lymph node dissection as the lymphatic drainage patterns are often unpredictable and variable.
引用
收藏
页码:29 / 32
页数:4
相关论文
共 12 条
[1]   A COMPARISON OF PROGNOSTIC FACTORS AND SURGICAL RESULTS IN 1,786 PATIENTS WITH LOCALIZED (STAGE-1) MELANOMA TREATED IN ALABAMA, USA, AND NEW-SOUTH-WALES, AUSTRALIA [J].
BALCH, CM ;
SOONG, SJ ;
MILTON, GW ;
SHAW, HM ;
MCGOVERN, VJ ;
MURAD, TM ;
MCCARTHY, WH ;
MADDOX, WA .
ANNALS OF SURGERY, 1982, 196 (06) :677-684
[2]   TUMOR THICKNESS, LEVEL OF INVASION AND NODE DISSECTION IN STAGE-1 CUTANEOUS MELANOMA [J].
BRESLOW, A .
ANNALS OF SURGERY, 1975, 182 (05) :572-575
[3]  
HAAGENSEN CD, 1972, LYMPHATICS CANCER, P441
[4]  
KAPELANSKI D P, 1979, Annals of Surgery, V189, P225, DOI 10.1097/00000658-197902000-00015
[5]  
MASTRANGELO M, 1982, CANCER PREVENTION PR, P1392
[6]  
NORMAN J, IN PRESS AM J SURG
[7]  
Sappey M. P. C., 1874, ANATOMIE PHYSL PATHO
[8]  
SHERMAN AI, 1953, CANCER, V6, P1238, DOI 10.1002/1097-0142(195311)6:6<1238::AID-CNCR2820060618>3.0.CO
[9]  
2-6
[10]  
SUGARBAKER EV, 1976, SURGERY, V80, P22